Home009420 • KRX
add
Hanall Biopharma Co Ltd
Previous close
₩40,600.00
Day range
₩38,650.00 - ₩40,950.00
Year range
₩28,500.00 - ₩52,000.00
Market cap
2.05T KRW
Avg Volume
562.88K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 36.84B | 11.74% |
Operating expense | 19.33B | 10.01% |
Net income | 221.93M | -30.39% |
Net profit margin | 0.60 | -38.14% |
Earnings per share | — | — |
EBITDA | 1.03B | 41.75% |
Effective tax rate | 58.60% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 27.22B | -55.67% |
Total assets | 212.92B | -11.77% |
Total liabilities | 41.56B | -4.74% |
Total equity | 171.36B | — |
Shares outstanding | 50.71M | — |
Price to book | 12.02 | — |
Return on assets | 0.50% | — |
Return on capital | 0.62% | — |
Cash Flow
Net change in cash
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 221.93M | -30.39% |
Cash from operations | 7.26B | -66.93% |
Cash from investing | -5.79B | -31.77% |
Cash from financing | -236.84M | -20.79% |
Net change in cash | 1.19B | -93.16% |
Free cash flow | -7.55B | -184.31% |
About
Founded
1973
Headquarters
Website
Employees
309